6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transcranial Direct-Current Stimulation Regulates MCT1-PPA-PTEN-LONP1 Signaling to Confer Neuroprotection After Rat Cerebral Ischemia–Reperfusion Injury

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract 

          Propionic acid (PPA) is a critical metabolite involved in microbial fermentation, which functions to reduce fat production, inhibit inflammation, and reduce serum cholesterol levels. The role of PPA in the context of cerebral ischemia–reperfusion (I/R) injury has yet to be clarified. Increasing evidence indicate that transcranial direct-current stimulation (tDCS) is a safe approach that confers neuroprotection in cerebral ischemia injury. Here, we show that the levels of PPA were reduced in the ischemic brain following a rat cerebral I/R injury and in the cultured rat cortical neurons after oxygen–glucose deprivation (OGD), an in vitro model of ischemic injury. We found that the decreased levels of transporter protein monocarboxylate transporter-1 (MCT1) were responsible for the OGD-induced reduction of PPA. Supplementing PPA reduced ischemia-induced neuronal death after I/R. Moreover, our results revealed that the neuroprotective effect of PPA is mediated through downregulation of phosphatase PTEN and subsequent upregulation of Lon protease 1 (LONP1). We demonstrated that direct-current stimulation (DCS) increased MCT1 expression and PPA level in OGD-insulted neurons, while tDCS decreased the brain infarct volume in the MCAO rats via increasing the levels of MCT1 expression and PPA. This study supports a potential application of tDCS in ischemic stroke.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s12035-022-03051-7.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Formation of propionate and butyrate by the human colonic microbiota

          The human gut microbiota ferments dietary non-digestible carbohydrates into short-chain fatty acids (SCFA). These microbial products are utilized by the host and propionate and butyrate in particular exert a range of health-promoting functions. Here an overview of the metabolic pathways utilized by gut microbes to produce these two SCFA from dietary carbohydrates and from amino acids resulting from protein breakdown is provided. This overview emphasizes the important role played by cross-feeding of intermediary metabolites (in particular lactate, succinate and 1,2-propanediol) between different gut bacteria. The ecophysiology, including growth requirements and responses to environmental factors, of major propionate and butyrate producing bacteria are discussed in relation to dietary modulation of these metabolites. A detailed understanding of SCFA metabolism by the gut microbiota is necessary to underpin effective strategies to optimize SCFA supply to the host.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism

            ABSTRACT The formation of SCFA is the result of a complex interplay between diet and the gut microbiota within the gut lumen environment. The discovery of receptors, across a range of cell and tissue types for which short chain fatty acids SCFA appear to be the natural ligands, has led to increased interest in SCFA as signaling molecules between the gut microbiota and the host. SCFA represent the major carbon flux from the diet through the gut microbiota to the host and evidence is emerging for a regulatory role of SCFA in local, intermediary and peripheral metabolism. However, a lack of well-designed and controlled human studies has hampered our understanding of the significance of SCFA in human metabolic health. This review aims to pull together recent findings on the role of SCFA in human metabolism to highlight the multi-faceted role of SCFA on different metabolic systems.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

              Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers. In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas. The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homology to tensin, a protein that interacts with actin filaments at focal adhesions. These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.
                Bookmark

                Author and article information

                Contributors
                che1971@126.com
                qiwan1@hotmail.com
                Journal
                Mol Neurobiol
                Mol Neurobiol
                Molecular Neurobiology
                Springer US (New York )
                0893-7648
                1559-1182
                3 October 2022
                3 October 2022
                2022
                : 59
                : 12
                : 7423-7438
                Affiliations
                [1 ]GRID grid.410645.2, ISNI 0000 0001 0455 0905, Institute of Neuroregeneration & Neurorehabilitation, Department of Neurosurgery, , Qingdao University, ; 308 Ningxia Street, Qingdao, 266071 China
                [2 ]GRID grid.449428.7, ISNI 0000 0004 1797 7280, Department of Biological Science, , Jining Medical University, ; Rizhao, Shandong China
                [3 ]GRID grid.415946.b, ISNI 0000 0004 7434 8069, Central Laboratory, Department of Neurology, , Linyi People’s Hospital, Qingdao University, ; 27 East Jiefang Road, Linyi, Shandong China
                [4 ]Qingdao High-tech Industrial Development District, Qingdao Gui-Hong Intelligent Medical Technology Co. Ltd, 7 Fenglong Road, Qingdao, China
                Author information
                http://orcid.org/0000-0002-1327-9851
                Article
                3051
                10.1007/s12035-022-03051-7
                9616768
                36190692
                102b0142-71ae-40d1-8c0e-5cc5ad0aa5f3
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 6 July 2022
                : 21 September 2022
                Funding
                Funded by: National Key R&D Program of China
                Award ID: 2019YFC0120000
                Award ID: 2018YFC1312300
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 82071385
                Award Recipient :
                Funded by: Key Research and Development Project of Shandong
                Award ID: 2019JZZY021010
                Award Recipient :
                Funded by: TaiShan Industrial Experts Program
                Award ID: No. tscy20200412
                Award Recipient :
                Categories
                Article
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2022

                Neurosciences
                propionic acid,cerebral ischemic stroke,neuroprotection,lonp1,tdcs
                Neurosciences
                propionic acid, cerebral ischemic stroke, neuroprotection, lonp1, tdcs

                Comments

                Comment on this article